Novel Growth and Death Related Interferon-Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN-βCompared with IFN-α2
- 1 December 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 23 (12) , 745-756
- https://doi.org/10.1089/107999003772084860
Abstract
Interferon (IFN)-dependent cellular effects are mediated by transcriptional induction of responsive genes, collectively referred to as IFN-stimulated genes (ISGs). Which ISGs regulate the potent antiviral, antiproliferative, apoptosis-inducing, antiangiogenic, and immunologic effects of IFNs remains largely undetermined. To identify genes that might be useful for predicting or targeting apoptosis induction in response to IFNs, WM9 melanoma cells were assessed. WM9 cells had equivalent antiviral activity in response to IFN-β and IFN-α2 but underwent apoptosis only in response to IFN-β. RNA samples from WM9 cells and WM35 cells, a second melanoma cell line, treated with IFN-α2 or IFN-β were assessed on oligonucleotide arrays. For 95% of genes assessed, IFN-β was more potent than IFN-α2 in inducing ISG expression. Using a 22,000-gene oligonucleotide array, the largest yet reported for assessing ISG induction, approximately 910 genes were identified as induced by IFN-β at 500 U/ml, and 260 ISGs were identified as significantly induced by IFN-β at both 50 and 500 U/ml. Of these 260, 209 were defined as new ISGs based on the array analysis. Confirmation by Northern blot or semiquantitative or quantitative PCR was undertaken for 28, and all were confirmed. Nearly half of the 260 genes were functionally categorized as encoding growth-regulatory proteins. Of the 104 with described growth-regulatory function, 71 were induced more than three times by 500 U/ml and twice by 50 U/ml IFN-β, and 48 of these were new ISGs. Included in this latter category were tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), XIAP-associated factor 1 (XAF1), galectin 9, a cyclin E binding protein, amphiphysin 1, MyD88, and several ubiquitin pathway genes. The diversity of stimulated genes suggests the full therapeutic potential of IFN regulation of gene expression has yet to be realized.Keywords
This publication has 58 references indexed in Scilit:
- Promyelocytic Leukemia Protein Sensitizes Tumor Necrosis Factor α-Induced Apoptosis by Inhibiting the NF-κB Survival PathwayJournal of Biological Chemistry, 2003
- Identification of X-linked Inhibitor of Apoptosis-associated Factor-1 as an Interferon-stimulated Gene That Augments TRAIL Apo2L-induced ApoptosisJournal of Biological Chemistry, 2002
- The role of Toll-like receptors and MyD88 in innate immune responsesInnate Immunity, 2000
- Cloning and Characterization of a Novel Human Ubiquitin-Specific Protease, a Homologue of Murine UBP43 (Usp18)Genomics, 2000
- A Novel Human Gene Encoding HECT Domain and RCC1-like Repeats Interacts with Cyclins and Is Potentially Regulated by the Tumor Suppressor ProteinsBiochemical and Biophysical Research Communications, 1999
- Differential Use of the βL Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNα2 and IFNβPublished by Elsevier ,1998
- Identification and Characterization of K12 (SECTM1), a Novel Human Gene That Encodes a Golgi-Associated Protein with Transmembrane and Secreted IsoformsGenomics, 1998
- Fas Antigen (CD95) and Hematopoietic Progenitor CellsLeukemia & Lymphoma, 1996
- Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cellsBiochemical and Biophysical Research Communications, 1983
- Human leukocyte and fibroblast interferons are structurally relatedNature, 1980